Physician profile
John Kroger
NPI 1740712785
$1,609.62
in general payments reported to CMS, 2019-2025
11 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $72.44 · 2022: $130 · 2023: $254 · 2024: $456 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,151 · Education: $12.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,150.99 |
| Education | $12.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $845.45 | 2020-2025 | Clareon, Ngenuity, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $154.83 | 2023 | Tecnis Iol, Tecnis Iol |
| Allergan, INC. | $125.00 | 2019 | |
| Abbvie INC. | $119.67 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $117.99 | 2019 | |
| Ocular Therapeutix, INC. | $105.74 | 2022 | |
| Bausch & Lomb Americas INC. | $61.61 | 2023-2025 | Vyzulta, Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $24.40 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $19.70 | 2024 | Tyrvaya |
| Astellas Pharma US INC | $18.26 | 2024 | Izervay |
| Lkc Technologies, INC. | $16.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kroger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.